Pink and Pearl campaign to link mammography visits with lung cancer screening at Christian Hospital.
Official title: Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
Run by Washington University School of Medicine · NCT07146568 · Data updated 2026-11-12
This program will try to increase lung cancer screening among women aged 50–80 who come for mammograms at Christian Hospital.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 5515 (estimated) |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 1 site (St Louis, Missouri) |
| Status | Recruiting |
| Started | February 23, 2026 |
| Main results expected | February 28, 2027 |
| Study ends | February 28, 2027 |
| Registry record updated | August 12, 2026 |
| Trial ID | NCT07146568 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 50–80 receiving screening mammography at Christian Hospital, especially those with a smoking history meeting lung screening criteria (about 20 pack-years, current or quit within 15 years).
✕Probably not a fit
Women outside the 50–80 age range, those not using Christian Hospital mammography services, men, or patients with limited life expectancy or prior lung cancer are unlikely to benefit from this campaign.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The breast radiology service at Christian Hospital will implement the Pink & Pearl campaign within mammography clinics to promote awareness, referral, and completion of low-dose CT lung cancer screening among eligible women. The campaign leverages existing nurse navigation and referral pathways to primary care or screening services to support shared decision-making. Evaluation is guided by the Integrated Screening Action Model and uses an explanatory sequential mixed-methods design that combines quantitative measures of screening uptake with qualitative interviews and surveys. Primary outcomes include changes in referral and completion rates for lung cancer screening and characterization of implementation barriers and facilitators.
Why it matters
Potential benefit: If successful, the campaign could increase use of low-dose CT screening and help detect lung cancer earlier in eligible women.
How similar studies have gone: Navigation and outreach programs have increased lung screening uptake in some settings, but explicitly linking mammography clinics to lung screening is a relatively novel approach with limited prior data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Eligibility Criteria - Interventional Study * Undergoing screening mammography at Christian Hospital * Between the ages of 50-80 years (inclusive) Eligibility Criteria - Survey and Interview Sub-Studies * Part of the interventional study * Reporting a 20 pack-year equivalent of either current smoking history or have quit in the past 15 years * Can speak and understand English * Not diagnosed with a serious health problem that will limit life expectancy (such as previous history of lung cancer, symptoms of lung cancer such as hemoptysis or unexplained weight loss of more than 6.8 kg (15 lb) in the previous year) * Willing and able to get treatment if lung cancer is found * Able to understand and willing to sign an IRB-approved written informed consent document Eligibility Criteria - Providers * At least 20 years of age * Involved in the breast radiology service or referred at least one patient to the Pink \& Pearl Campaign * Able to provide verbal consent to participate in the interview
Where it's running
-
Barnes-Jewish Christian Hospital
St Louis, Missouri, United States Recruiting
Study contacts
- Principal investigator: Beryne Odeny, M.D., MPH, Ph.D. — Washington University School of Medicine
- Study coordinator: Beryne Odeny, M.D., MPH, Ph.D.
- Email: beryne@wustl.edu
- Phone: 314-362-1183
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating the Pink and Pearl Campaign for Lung Cancer Screening
This study is testing if the Pink and Pearl Campaign can encourage women aged 50-80 getting mammograms to also get screened for lung cancer.
-
Innovative care program for lung cancer survivors
This study is testing a new care program designed to help lung cancer survivors in Kentucky feel better and improve their quality of life compared to standard care.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.